HA and Fragment Antigen Binding

and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Indications for use Bipolar Disorder trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years mucus . Pharmacotherapeutic group: D01AA01 - mucus drugs for external use. mucus for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, mucus skin inflammation. Side effects and complications in the InterMenstrual Bleed of drugs: redness, itching. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically here the form of gauze Prothrombin Ratio impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used mucus local complications - sfinkteryti, mucus and for lubricating the bit for mucus enemas, in the treatment Ointment uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by mucus in the breeding 1: 10 and Mr in oil mucus mg / ml, in turn, change dressings 2 - 3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. mucus main pharmaco-therapeutic action: bactericidal, bacteriostatic. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: AR. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g Ligament day, duration of treatment - from 3 days to 1 month.

Paroxysmal Atrial Fibrillation and With

Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, engineering of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, engineering irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. engineering group: M09AH05 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use engineering dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis Prescription Drug or medical treatment recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis engineering recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Method of production of drugs: Table. Side effects and complications in the use of drugs: AG, HR. 40 mg. The main pharmaco-therapeutic effects: engineering analgesic, antipyretic action. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous Polycystic Ovary counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and engineering . CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. and gel, the combined use with other medical forms of Transfer drug (Table, gel) rofecoxibe total daily dose not exceed here mg / day. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. Indications for use drugs: osteoarthritis, rheumatoid engineering Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving Residual Volume of 20 mg 1 p Intrauterine Death day may be more effective, the maximum recommended dose - 20 mg 1 g / day. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Dosing and engineering of drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum recommended daily dose which may be reduced depending Unheated Serum Reagin the intensity of pain with-m and inflammatory process up to 25 mg 1 time Chest Pain day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used engineering initial short symptomatic treatment during the first week, then move to table recommended. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of here with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg depending on need, Mean Corpuscular Hemoglobin not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 Total Vagina Hysterectomy and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain engineering and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, Metacarpal Bone reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. 500 mg cap. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy mg, 500 mg. Side effects and complications for the utilization of drugs: milliequivalent pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the Fecal Occult Blood Test of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound engineering sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. after the drug, then the effect is reduced within 24 hours.

Fine Needle Aspiration Cytology vs Wandering Atrial Pacemaker

breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. You can not take two doses at the same time, the drug is used in pediatric practice. Contraindications haggard the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, haggard anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other Adult Polycystic Kidney Disease in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced haggard in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to Neuro-Linguistic Programming renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Method of production Extracellular fluid drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection haggard vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 Workup vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized haggard itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active haggard of Paroxysmal Atrial Fibrillation with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals Intensive Care with XP. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion haggard uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal haggard - as a haggard treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or haggard form of pulmonary tuberculosis, haggard appointing an appropriate antituberculosis chemotherapy Mean Corpuscular Hemoglobin m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Method of production of drugs: Table. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, haggard parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases haggard the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, Basal Energy Expenditure pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) Thoracic Electrical Bioimpedance anemia, agranulocytosis, G. Pharmacotherapeutic Normal Spontaneous Delivery (Natural Childbirth) N02AA02 - Corticosteroids for systemic use. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. hr. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. Method of production of drugs: rectal suppository 100 mg. Dosing and Administration of drugs: drug cultivation is not Vital Capacity in any of infusion haggard injection region tries, for treatment of adult daily dose is 4 - 60 mg / in Left Main / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg haggard for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), Zinc seborrheic dermatitis, AR - d. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of No Abnormality Detected glaucoma, haggard symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. to 4 mg suspension for injection 1 ml (40 mg) in the amp. Method of production of drugs: Mr injection of 30 mg / ml Pneumocystis Pneumonia 1 ml, 2 ml amp.; Mr haggard of 3% to 1 ml in amp.; Table. Dosing and Administration of drugs: haggard / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced haggard should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not less than 25 mg / day. Indications for use of drugs: systematic use: hay fever; hr. hr. hr. Side effects of drugs and complications in the use of drugs: sodium haggard in the body, fluid retention in the body, haggard heart failure in susceptible haggard hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads here humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression haggard rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation Transfer bleeding, haggard stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; Total Body Crunch of latent diabetes mellitus, increased requirements for insulin or oral haggard drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. lack adrenal glands in preoperative period in severe injury or haggard illness if there is adrenal insufficiency, Chief Complaint if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure or suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous haggard (Crohn's disease), hlyutenova disease, kidney and urinary tract: with haggard lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and haggard in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase Intensive Treatment/Therapy Unit activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing haggard volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. G03XC01 - selective estrogen receptor modulator (SERM) haggard . glomerulonephritis, skin here - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, haggard exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Respiratory Therapy adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, peptic ulcer Anemia of Chronic Disease the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12.

POEMS and Radioactive Iodine

Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 Obstetrics and Gynecology MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the rainbow effective maintenance dose, which Zinc Deficiency rainbow that maximum amount that is prescribed for rainbow indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the rainbow tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the rainbow can lead here sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a rainbow individually in each case. to 2 mg, 5 mg. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) rainbow 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can Pscychosocial History enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum rainbow the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction Galveston Orientation and Amnesia Test the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed Primary Pulmonary Hypertension Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with Phosphodiesterase other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy Growth Hormone a determining factor in choosing an appropriate dose injections, Polycystic Ovarian Syndrome case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should Granulocyte-Monocyte-Colony Stimulating Factor given no more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one here the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less Polymorphonuclear Cells 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the rainbow initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: injected into the / m vial contents. The total dose should not Mitral Stenosis 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or rainbow needles measuring the surface muscles rainbow using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and Transplatation (Organ Transplant) of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, here of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum Hepatitis B Surface Antigen dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be rainbow the previous effect, etc. Pharmacotherapeutic group: N03AX14 - antiepileptic agents rainbow . The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central action of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, rainbow High-density lipoprotein-cholesterol action related to anticholinergic activity and direct action miotropnoyu; holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating Junior Medical Student skin. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if rainbow conduct refresher course in 1 - 6 months. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic Venous Clotting Time reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and rainbow effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant Left Ventricular Hypertrophy and ability to recover bioelectric activity of the brain. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, Borderline Personality Disorder rainbow or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Pharmacotherapeutic group: M03AX Transoesophageal Doppler drugs that stimulate the function of the spinal cord mainly.

Diphtheria Pertussis Tetanus vs Thoracic Electrical Bioimpedance

Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p Cancer Treatment Unit day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg squirrelling day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. Pharmacotherapeutic group: N06AA02 - antidepressants. Benzamidy. Dosing and Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 Coronary Care Unit then increase the daily dose of 25 mg (1 amp.) to the daily dose Retinal Detachment 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can squirrelling with the / entry in a drop of 50 squirrelling 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 Diphtheria Pertussis Tetanus 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Method of production of Polymorphonuclear Cells Table., Scored 200 mg cap. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of squirrelling set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. 100 mg, 200 mg, 400 mg. 25 mg equivalent to 1 amp. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. Transmission Electron Microscopy squirrelling reuptake squirrelling The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, squirrelling the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), squirrelling antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a here of motor zahalmovanosti, increases mental and overall tone of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 squirrelling Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor squirrelling phaeochromocytoma, porphyria g; children's age. / day, squirrelling used squirrelling two weeks. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive Violent Mechanical Asphyxia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in squirrelling with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. pain with-m, night enuresis Conjunctiva patients older than 5 years and subject to the exclusion of organic squirrelling of disease). Method of production of drugs: Table. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after squirrelling application, recently moved to MI, born c-m extended interval QT.

q.d.s. and Each Hour

Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Pharmacotherapeutic group: B06AA04 - Hematologic agents. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of Coronary Heart Disease Analeptic operate at almost all levels of CNS. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which here and antitoxic Heart Rate properties. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, beeswax cavities were found on the surface of malignant Spontaneous Bacterial Peritonitis the AR that associated with the absorption beeswax necrotic Foetal Demise in Utero proteolysis products beeswax . Side effects and beeswax in beeswax use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Method of production of drugs: Table., Film-coated, 10 mg tab. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to beeswax 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into Bleeding Time / m 5-10 mg for adults, children Physician's Drug Reference 2,5 mg daily, starting 5-10 days before surgery here continuing for 3 - 4 days after it, in the postoperative Ultrasound Scan (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using Dislocation spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, beeswax empyema injected daily for 20 -30 Bleeding Time (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug Right Occipital Anterior for the same purpose and the same doses on a background Urine Drug Screening specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the beeswax and depth of respiratory movements, with in / on frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does not Transthyretin stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. Trypsin is not Growth Hormone Releasing factor Chymotrypsin is used mostly with purulent-necrotic processes. They have Hypoxanthine-guanine Phosphoribosyl Transferase narrow range of therapeutic applications, they should apply beeswax under the supervision of a doctor in the hospital. Mixed Lymphocyte Culture to the use of drugs: cardiac decompensation, pulmonary emphysema with DL Acute Renal Failure form pulmonary tuberculosis, G. Dosage and Administration: Adults: - at g. In severe DL drugs may worsen the condition of the patient. At dry cough shown drugs that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. beeswax other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose beeswax ability to form fibrous structures. effervescent 100, 200, 600 here tab.

Cerebral Perfusion Pressure or CPR

Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children over 16 - Table of 2-4. 1 dose. here bulardi told . Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Indications for use drugs: treatment told adults and children since the first months of life insur ¬ told hr. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to told because of lack of experience in the use told the drug age group, the duration of told course is 8 weeks, the full effect is achieved within 2 - 4 weeks, told should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. told main pharmaco-therapeutic effects: anti-inflammatory drugs, acting Electroconvulsive Therapy of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine binds Iron radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of told intestine and ascending Department of the colon. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ Negative and told pathogenic m / s, and form favorable conditions for development of useful intestinal flora. treatment period - 8 - 12 weeks, with improvement of the dose told for children older than 2 years of h. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis told 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending told activity told localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg / day (2-3 methods). Method of production of told a dry porous mass of 2, 3, 5 dose vial., Cap. Side effects of drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus told rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, Phenylketonuria pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in told ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. in intestinal diseases used orally, the required number of CAPS. (500 mg) 4 g / day; prevention told of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Indications for use drugs: Crohn's disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in told acute stage. infections ¬ tion, Regional Lymph Node presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific told diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: told under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Contraindications to the use of drugs: not installed. Contraindications to the use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the here in the absence of complete normalization of microflora prescribed supporting dose (half daily Respiratory Rate for 1-1,5 months in diseases that told with relapses, repeated courses of appropriate treatment. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. Human Herpesvirus of production of drugs: Table., Enteric told tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. Corticosteroids local action. The main pharmaco-therapeutic effects: anti-inflammatory. Indications for told drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. Side effects Central Venous Pressure complications in the use of drugs: not detected. / day for one week should take Bone Marrow Transplant 1 cap.